BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24954511)

  • 1. Effect of a low dose combined oral contraceptive pill on the hormonal profile and cycle outcome following COS with a GnRH antagonist protocol in women over 35 years old.
    Bakas P; Hassiakos D; Grigoriadis C; Vlahos NF; Liapis A; Creatsas G
    Gynecol Endocrinol; 2014 Nov; 30(11):825-9. PubMed ID: 24954511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual suppression with oral contraceptive pills in GnRH antagonist cycles for patients with polycystic ovary syndrome undergoing intracytoplasmic sperm injection.
    Ozmen B; Sükür YE; Seval MM; Ateş C; Atabekoğlu CS; Sönmezer M; Berker B
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():137-40. PubMed ID: 25461367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.
    Nyachieo A; Spiessens C; Chai DC; Mwenda JM; D'Hooghe TM
    Fertil Steril; 2009 Feb; 91(2):602-10. PubMed ID: 18328482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
    Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
    Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
    Andersen AN; Witjes H; Gordon K; Mannaerts B;
    Hum Reprod; 2011 Dec; 26(12):3413-23. PubMed ID: 21954280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial.
    Haydardedeoglu B; Kilicdag EB; Parlakgumus AH; Zeyneloglu HB
    Arch Gynecol Obstet; 2012 Sep; 286(3):763-9. PubMed ID: 22569710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol.
    Cédrin-Durnerin I; Bständig B; Parneix I; Bied-Damon V; Avril C; Decanter C; Hugues JN
    Hum Reprod; 2007 Jan; 22(1):109-16. PubMed ID: 16936304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial.
    Garcia-Velasco JA; Bermejo A; Ruiz F; Martinez-Salazar J; Requena A; Pellicer A
    Fertil Steril; 2011 Sep; 96(3):590-3. PubMed ID: 21718992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial.
    Kolibianakis EM; Papanikolaou EG; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    Hum Reprod; 2006 Feb; 21(2):352-7. PubMed ID: 16269449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of desogestrel and ethinyl estradiol pretreatment in superovulation cycles with short protocol].
    Zhao JZ; Lin XH; Huang XF; Lin JJ; Lin WQ; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):102-5. PubMed ID: 18683747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients.
    Tehraninejad ES; Nasiri R; Rashidi B; Haghollahi F; Ataie M
    Arch Gynecol Obstet; 2010 Sep; 282(3):319-25. PubMed ID: 20379731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients.
    Rombauts L; Healy D; Norman RJ;
    Hum Reprod; 2006 Jan; 21(1):95-103. PubMed ID: 16253978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection.
    Kim CH; Jeon GH; Cheon YP; Jeon I; Kim SH; Chae HD; Kang BM
    Fertil Steril; 2009 Nov; 92(5):1758-60. PubMed ID: 19523618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
    Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of GnRH antagonist cycles with and without oral contraceptive pretreatment in potential poor prognosis patients.
    Bendikson K; Milki AA; Speck-Zulak A; Westphal LM
    Clin Exp Obstet Gynecol; 2006; 33(3):145-7. PubMed ID: 17089576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.